This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

Analysts' Actions: DE, CAT, ADM, NKE, OPEN

Stocks in this article: OPEN DE CME CAT ADM BHI THC HCA ANF GLW UA NKE

>>Countdown to our free event: Meet the Real Money Pros: Market Strategies for 2012



NEW YORK ( TheStreet) -- CHANGE IN RATINGS, EPS

Abercrombie & Fitch (ANF) cut from Conviction Buy List at Goldman. Valuation call, as the stock is up 32% over the past 11 months.

Aeropostale (ARO) upgraded at Goldman from Sell to Neutral. The company can expand margins in the coming quarter.

Amedisys (AMED) downgraded to sell at TheStreet Ratings.

American Tower (AMT) numbers adjusted at Citigroup. Shares of AMT now seen reaching $65. Estimates lowered on FX headwinds. Buy rating.

American Tower estimates, target raised at JP Morgan. Shares of AMT now seen reaching $62. Estimates also increased on Core and Sprint MLA.

AmerisourceBergen (ABC) estimates increased at UBS. ABC estimates increased through 2013. Positive operating trends. Maintain $47 price target and Buy rating.

Ann (ANN) downgraded at Goldman from Neutral to Sell. Margins are peaking and the company is leveraged to slower macro growth.

Archer Daniels Midland (ADM) numbers cut at Morgan Stanley. Shares of ADM now seen reaching $37. Estimates also reduced, given lower oilseed margins. Overweight rating.

Atmel (ATML) downgraded at Needham from Strong Buy to Buy. Company could face inventory rebalancing in the next couple of quarters.

Atmel upgraded to buy at TheStreet Ratings.

Autodesk (ADSK) target cut at UBS to $43. VARs continue to plod through a sluggish economic environment. Buy rating.

Baker Hughes (BHI) numbers cut at Credit Suisse. Shares of BHI now seen reaching $80. Estimates also reduced, given lower expected North American pricing. Outperform rating.

Baker Hughes estimates increased at Sterne Agee. BHI estimates raised through 2012. Bullish rig count forecast. Maintain $71 price target and Buy rating.

Baker Hughes estimates, target cut at UBS. Shares of BHI now seen reaching $82. Estimates also increased as overall story is still in on track despite a sloppy 3Q. Buy rating.

Catalyst Health (CHSI) numbers lowered at Credit Suisse. Shares of CHSI now seen reaching $62. Estimates also cut, to match the company's new guidance. Outperform rating.

Caterpillar (CAT) rated new Overweight at Morgan Stanley. Valuation call, based on a $125 price target.

CME Group (CME) numbers lowered at Jefferies. CME estimates were cut through 2012. Volume has moderates and expenses could be back on the rise. Buy rating and new $297 price target.

CME Group estimates lowered at UBS through 2012. MF Global bankruptcy may be a blow to the futures industry as a whole. Buy rating.

1 of 4

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs